Pharmacodynamic Studies of Fluorescent Diamond Carriers of Doxorubicin in Liver Cancer Cells and Colorectal Cancer Organoids.
Ron FiresteinCezary MarcinkiewiczLinyan NieHui Kheng ChuaInes Velazquez QuesadaMarco TorelliMark SternbergBojana GligorijevicOlga ShenderovaRomana SchirhaglGiora Z FeuersteinPublished in: Nanotechnology, science and applications (2021)
The rapid uptake and profound cancer inhibition observed using FDP-DOX in clinically relevant cancer models, highlight FDP-DOX promise for cancer chemotherapeutics. We also conclude that the in vitro data justify further investment in in vivo POC studies.